Clinical trial
Evaluation of Atorvastatin Treatment on Carotid Plaque.
NCT00343655 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Terminated
Key facts
| NCT number | NCT00343655 |
|---|---|
| Title | Evaluation of Atorvastatin Treatment on Carotid Plaque. |
| Official title | A Randomized Clinical Trial Of Atorvastatin 10 Mg And 80 Mg In The Reversal Of Or Stabilization Of Carotid Atheroma Lipid Pool |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 160 |
| Start date | Jan 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 23, 2006 |
| Last update posted | Feb 18, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: